Alan Henry Raffensperger
Direktor/Vorstandsmitglied bei SPAGO NANOMEDICAL AB
Ursprung des Netzwerks ersten Grades von Alan Henry Raffensperger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.
12
| Subsidiary | Miscellaneous Commercial Services | 12 |
| Public Company | Biotechnology | 11 | |
Masimo Sweden AB
 Masimo Sweden AB Electronic Equipment/InstrumentsElectronic Technology Masimo Sweden AB develops and markets ultra-small gas monitoring probes. It sells mobile multigas analyzers that enable to measure respiratory gases in any clinical application. The firms products include IRMA Mainstream Analyzers, ISA Sidestream Analyzers, Nomoline Sampling Lines, EMMA Capnometers, and EMMA Carnograph. The company was founded by Anders Eckerbom and Robert Zyzanski in 1989 and is headquartered in Danderyd, Sweden.
10
| Subsidiary | Electronic Equipment/Instruments | 10 |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
| Public Company | Medical Specialties | 6 | |
Inceptua Ltd.
 Inceptua Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Inceptua SA, Inceptua Ltd. provides business support services. The company is based in Windsor, UK. Founded in 2011.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Rolf Lufts Stiftelse Foer Diabetesforskning
2
| Private Company | 2 | |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA.
2
| Subsidiary | Medical Specialties | 2 |
Amgen International AG
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alan Henry Raffensperger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| CAREDX, INC | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| SIG GROUP AG | Industrial Machinery | Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| BIOTAGE AB | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Artema Medical AB
 Artema Medical AB Medical SpecialtiesHealth Technology Part of Getinge AB, Artema Medical AB is a Swedish company that develops, manufactures, and markets medical breathing gas analyzers and related accessories. The company is based in Sundbyberg, Sweden. The company was founded by Anders Eckerbom, Robert Zyzanski. Artema Medical was acquired by Cardiac Science, Inc. on January 01, 2002 for $17.80 million. | Medical Specialties | Founder Founder | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| Copenhagen Business School | College/University | Director/Board Member Masters Business Admin | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| Chalmers University of Technology | College/University | Graduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree | |
| Technische Universität München | College/University | Doctorate Degree Graduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Investor Relations Contact | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| University of Lund | College/University | Graduate Degree Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| University of Oslo | College/University | Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| BIOATLA, INC. | Biotechnology | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Catalyst Medical Solutions, Inc. | Founder | ||
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member President |
Statistik
International
| Schweden | 22 |
| Vereinigte Staaten | 16 |
| Deutschland | 5 |
| Schweiz | 4 |
| Dänemark | 4 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 303 |
| Corporate Officer/Principal | 160 |
| Chairman | 92 |
| Independent Dir/Board Member | 79 |
| Chief Executive Officer | 77 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Eugen Steiner | 44 |
| Bo Jesper Hansen | 34 |
| Yvonne Christine Mårtensson | 27 |
| Hans Andreasson | 23 |
| Robert Booth | 22 |
| Jeff Jonas | 21 |
| Karin Hehenberger | 21 |
| Hans Fredrik Mattsson | 21 |
| Guido Oelkers | 19 |
| Thomas Johannes W. Dittrich | 18 |
| Peter Johann | 18 |
| Lee Babiss | 17 |
| Christian Schneider | 17 |
| Matthew Gantz | 16 |
- Börse
- Insiders
- Alan Henry Raffensperger
- Unternehmensverbindungen
